Promising brain tumor trial for kids pulled before it started
NCT ID NCT03554707
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a new drug called SGT-53 combined with radiation and chemotherapy in children whose brain or spinal cord tumors had come back or were not responding to treatment. The goal was to see if the combination was safe and could shrink tumors. However, the study was withdrawn before any patients were enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD CNS TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States